Lumbrokinase Supplement: The Earthworm Enzyme With a Boring Name

The Oasis Health Journal · Submitted August 23, 2026 · 8:02 PM EDT

By Winifred Oduya · Edited by Gus Feld

Lumbrokinase is what you call it when you extract an enzyme from earthworms and need it to sound like something a cardiologist might prescribe instead of something a child digs up after rain. The lumbrokinase supplement market has decided this enzyme supports circulation. The enzyme, which evolved to help worms digest decaying leaves, has not been consulted on its career change.

Lumbrokinase is a fibrinolytic enzyme, meaning it breaks down fibrin, the protein your blood uses to form clots. Earthworms produce it to process organic matter in soil. Researchers extracted it, named it after the worm's taxonomic family, and began testing whether the thing that helps a worm eat dirt might also help a human not die of a stroke. That leap required optimism, funding, and a willingness to overlook what the enzyme was actually doing when they found it.

It is one of several enzymes the supplement industry has discovered, renamed, and sold as cardiovascular support despite a nearly complete absence of human trials showing cardiovascular outcomes. What it does have: rodent data, test-tube activity, and a name that does not sound like it came from bait.

What The Earthworm Enzyme Supplement Research Actually Measured

In a 2023 study published in BioMed Research International, researchers tested lumbrokinase on rats recovering from abdominal surgery. The enzyme reduced post-surgical adhesion, the unwanted scar tissue that forms between organs after an operation. Treated rats had significantly less adhesion severity and thinner peritoneal tissue compared with untreated controls. The study also tested lumbrokinase on human fibroblast cell cultures and found it inhibited cell migration and adhesion without harming cell growth, working by suppressing the AP-1/ICAM-1 signaling pathway, which is how cells stick to things they should not stick to.

That is a wound-healing study. In rats.

It measured tissue scarring, not blood flow. It did not measure cholesterol, clot formation, stroke risk, or anything happening inside a circulatory system. The conclusion was that lumbrokinase might prevent surgical complications in rodents. The cardiovascular support claim came from marketing, not the methods section.

Lumbrokinase Circulation Support: The Label vs. The Lab

A 2024 review in Heliyon surveyed fibrinolytic enzymes from microbial and non-microbial sources. Lumbrokinase made the list as a non-microbial fibrinolytic enzyme with demonstrated activity in laboratory conditions. The review noted that fibrinolytic enzymes break down fibrin and that this property makes them candidates for thrombolytic therapy.

Candidates. Not therapies. Not treatments. Candidates, like a man at an audition who has not yet been called back.

The review did not cite a single human trial measuring lumbrokinase's effect on circulation, clot prevention, or cardiovascular events. It confirmed the enzyme has fibrinolytic activity in a test tube, which is a factual sentence that answers no question a person buying a supplement has ever asked. Test tubes do not have heart attacks. They do not take supplements. They do not worry.

The circulation support framing on lumbrokinase labels rests on this logic: the enzyme breaks down fibrin in lab conditions, fibrin is involved in clot formation, clots cause heart attacks and strokes, therefore the enzyme supports your circulation. That is four steps. Only the first one has been demonstrated in a controlled setting involving humans. The other three are a business plan.

Lumbrokinase is sold as a fibrinolytic enzyme supplement, often positioned as an alternative to nattokinase, another enzyme with more human data and a less alarming origin story. Nattokinase comes from fermented soybeans. Lumbrokinase comes from worms. Both break down fibrin. One has been studied in small human trials for blood pressure and circulation markers. The other has been studied in rats for post-surgical scarring and sold to humans anyway.

Where To Buy Lumbrokinase Supplement, And What You Are Actually Buying

Lumbrokinase supplements are available online and in stores that sell enzymes extracted from improbable sources. The labels describe it as supporting healthy circulation, cardiovascular function, and blood flow. The studies describe it as preventing adhesion in rats and breaking down fibrin in a dish. These are not the same claim. They are not even in the same room.

Dosage recommendations vary by manufacturer because no standardized human trial has established an effective dose for any cardiovascular outcome. Most products suggest 20 to 60 milligrams per day, which is a range pulled from rodent studies, scaled up by bodyweight, and sold with confidence.

The best lumbrokinase supplement is the one that lists its enzyme activity in fibrinolytic units, names its extraction source, does not promise you will live forever, and acknowledges somewhere on the bottle that this entire category is built on enzyme activity and a theory. That is also the rarest kind. Honesty does not sell as well as hope.

Lumbrokinase vs nattokinase is a comparison the industry enjoys because it makes both sound like established medicines competing on merit. Nattokinase has a 2022 review in Foods summarizing its production, activity, and cardiovascular studies, most of them small and many of them industry-funded, but at least conducted on humans. Lumbrokinase has rodent surgery data and the enzyme activity of something that digests dirt. If you are comparing them for heart health, you are comparing one small body of evidence to none.

Lumbrokinase Heart Health: What Has Not Been Established

No published study has measured lumbrokinase's effect on human blood pressure, cholesterol, clotting time, stroke risk, or heart attack incidence. The enzyme has fibrinolytic activity, meaning it can break down fibrin under controlled conditions. That activity has not been translated into a demonstrated health outcome in people. Not one.

The post-surgical adhesion study was promising for rats facing abdominal surgery. It was not a cardiovascular trial. The fibroblast study showed the enzyme affects cell behavior in culture. It did not involve blood, clots, or circulation. These are real findings. They are also not the findings being sold.

The supplement industry has taken 'fibrinolytic enzyme' and built an entire cardiovascular narrative around it, the same way it took 'antioxidant' and sold it as a solution to aging, disease, and poor life choices. The strategy works because the science sounds plausible and most people do not read past the abstract. Lumbrokinase breaks down fibrin. That is true. It supports your circulation, thins your blood, prevents clots, and keeps your heart healthy. That is marketing dressed in a lab coat.

The research shows lumbrokinase is a real enzyme with real activity and no human cardiovascular data. The labels show it is a product with impressive claims and an earthworm on the ingredient list. If those two things sound like they belong together, you are ready to work in supplement marketing.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems, Heliyon (2024).
2. Diverse origins of fibrinolytic enzymes: A comprehensive review, Heliyon (2024).
3. Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway, BioMed research international (2023).
4. Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review, Foods (Basel, Switzerland) (2022).